{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-065810","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2026-06-05T20:10:29+00:00","discovered_at":"2026-06-05T20:11:00.265481+00:00","generated_at":"2026-06-05T20:21:00.042021+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OptimizeRx CCO Theresa Greco to depart June 15; advisory role through June 2027","bullets":["Greco's separation effective June 15, 2026; she will serve as advisor through June 15, 2027.","She receives 12 months' base salary continuation at $380,000/yr, a $209,000 lump sum bonus target, and COBRA reimbursement for 12 months.","Equity grants continue to vest during the 12-month advisory term; change-of-control special bonus preserved.","Greco subject to 12-month non-compete and non-solicit obligations under Business Protection Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-065810","json":"https://secwatch.observer/filing/0001213900-26-065810.json","markdown":"https://secwatch.observer/filing/0001213900-26-065810.md","text":"https://secwatch.observer/filing/0001213900-26-065810.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/0001213900-26-065810-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/ea0293598-8k_optimize.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T20:21:00.042021+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ecaf12519","claim":"Theresa Greco departed as Chief Commercial Officer at OptimizeRx Corp.","evidence_excerpt":"Accordingly, effective as of the Separation Date, Ms. Greco will no longer serve as the Company’s Chief Commercial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/0001213900-26-065810-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}